PRESS RELEASE – IPH5201 (CD39 mAb) to advance into Phase 2
3 June 2022
OREGA enters into a License Agreement with Genmab
6 December 2022
Jeremy BASTID, CEO of OREGA Biotech, will attend the upcoming 37th SITC annual meeting to be held November 8-12 2022 (Boston, MA & virtual).
